<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Cardiology Devices]]></title>
    <link>https://www.leadingmarketresearch.com/medical-devices-in-vitro-diagnostics/medical-devices/cardiology-devices</link>
    <description><![CDATA[Cardiology Devices]]></description>
    <pubDate>Sat, 11 Jul 2026 19:36:29 +0000</pubDate>
    <generator>Zend_Feed</generator>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[2025 Medical Device Market Leading Companies Capabilities, Goals and Strategies]]></title>
      <link>https://www.leadingmarketresearch.com/medical-device-market-leading-companies-capabilities-goals-and-strategies</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation to the leading competitors.
<p>The series includes current assessments of more than 1,000 companies worldwide. Depending on the company’s business nature and structure, the assessments include all or some of the following analyses: Organization and Management, Acquisitions and Divestitures, Facilities and Employees, Research and Development, Technological Know-How, Key Products, Marketing Capabilities, Financial Results, Strengths and Weaknesses, and Strategic Directions. ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-210076"><span class="price">$3,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 12 Sep 2019 15:55:15 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cardiac Monitoring &amp; Cardiac Rhythm Management Devices Market Size, Share, and Analysis, By Cardiac Monitoring Devices (Implantable Loop Recorder, ECG Devices, Event Monitors, Cardiac Output Monitoring), By Rhythm Management Devices]]></title>
      <link>https://www.leadingmarketresearch.com/cardiac-monitoring-and-cardiac-rhythm-management-devices-market-size-sha</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size, Share, and Analysis, By Cardiac Monitoring Devices (Implantable Loop Recorder, ECG Devices, Event Monitors, Cardiac Output Monitoring), By Rhythm Management Devices (Defibrillators, Cardiac Resynchronization Therapy Devices, Pacemakers), By End-User (Hospitals, Home & Ambulatory Care, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
PRODUCT OVERVIEW
Cardiac Monitoring & Cardiac Rhythm Management Devices Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 8.4% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 31.2 billion and is projected to reach USD 75.8 billion by the completion of 2034.
Cardiac monitoring refers to continuous observation and recording of the electrical activity and rhythm of the heart to detect irregularities and anomalies. It uses various devices such as electrocardiogram (ECG or EKG) monitors, along with Holter monitors and implantable loop recorders. These tools pro...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-230447"><span class="price">$4,950.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 18 Feb 2025 16:20:57 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Global Cardiac Implant Devices Market Research Report 2022-2032]]></title>
      <link>https://www.leadingmarketresearch.com/global-cardiac-implant-devices</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">The report titled Cardiac Implant Devices Market- Analysis of Market Size, Share & Trends for 2014 - 2020 and Forecasts to 2031 is anticipated to reach Market Value According to a study by Fatpos Global. According to the report, emphasizes on the detailed understanding of some decisive factors such as size, share, sales, forecast trends, supply, production, demands, industry and CAGR in order to provide a comprehensive outlook of the global market.
...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228435"><span class="price">$4,450.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 22 Feb 2023 10:42:50 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Global Cardiac Rhythm Management Devices Market Research Report 2022-2026]]></title>
      <link>https://www.leadingmarketresearch.com/global-cardiac-rhythm-management-devices-market-research-report-2022-2026</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Cardiac Rhythm Management Devices Report by Material, Application, and Geography – Global Forecast to 2026 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Cardiac Rhythm Management Devices market is valued at USD XX million in 2022 and is projected to reach USD XX million by the end of 2026, growing at a CAGR of XX% during the period 2022 to 2026.

The report firstly introduced the Cardiac Rhythm Management Devices basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand an...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-224707"><span class="price">$3,200.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 13 Apr 2022 14:34:41 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Interventional Cardiology Devices Market Insights, Competitive Landscape and Market Forecast–2025]]></title>
      <link>https://www.leadingmarketresearch.com/interventional-cardiology-devices-market-insights-competitive-landscape-an</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">DelveInsight’s ‘Interventional Cardiology Devices-Market Insights, Competitive Landscape and Market Forecast - 2025’ report delivers an in-depth understanding of Interventional Cardiology Devices and the historical and forecasted Interventional Cardiology Devices market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.

The Interventional Cardiology Devices market report provides an overview of Interventional Cardiology Devices, reasons to get Interventional Cardiology Devices as well as its advantages and limitations. Additionally, the report provides insight on the Interventional Cardiology Devices market share of the individual Interventional Cardiology Devices devices, current and forecasted Interventional Cardiology Devices market size from 2017 to 2025 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Interventional Cardiology Devices Overview
Interventional Cardiology devices are used in...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-217526"><span class="price">$4,750.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 05 Feb 2021 15:36:57 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Pacemakers Pipeline Insight and Competitive Landscape, 2020]]></title>
      <link>https://www.leadingmarketresearch.com/pacemakers-pipeline-insight-and-competitive-landscape-2020</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">DelveInsight’s, “Pacemakers – Pipeline Insight and Competitive Landscape, 2020,” report provides comprehensive insights about 20+ companies and 25+ pipeline devices in Pacemakers pipeline landscape. The Pacemakers market is expected to undergo significant growth in the approaching years owning to an increasing prevalence of cardiovascular disorders around the world. The growing aging population is also a major growth factor for as it is more susceptible to diseases like Cardiac arrest, Heart failure and High blood pressure. Therefore, due to an increase in demand of such devices, huge investment is being made on R&D activities in cardiological sector, which is the major reason for an extensive pipeline in this segment. This report provides a detailed study of the emerging pacemakers along with competitive landscape to help better understand the emerging pacemaker devices. 
Geography Covered
• Global coverage
Pacemakers Overview 
Pacemakers: Understanding
A pacemaker is a small device that&#039;s placed in the chest or abdomen to help control abnormal heart rhythms. Thi...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-215985"><span class="price">$3,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 15 Oct 2020 14:02:56 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cardiac Rhythm Management Devices - Medical Devices Pipeline Assessment, 2018]]></title>
      <link>https://www.leadingmarketresearch.com/cardiac-rhythm-management-devices-medical-devices-pipeline-assessment-20</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s Medical Devices sector report, “Cardiac Rhythm Management Devices - Medical Devices Pipeline Assessment, 2018&quot; provides an overview of Cardiac Rhythm Management Devices currently in pipeline stage.<br><br>The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Rhythm Management Devices pipeline products.<br><br>This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData&#039;s team of industry experts.<br><br>*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.<br><br><b>Scope</b><br><br>- Extensive coverage of the Cardiac Rhythm Management Devices...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-202110"><span class="price">$4,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 06 Aug 2018 13:30:23 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[US Market Report for Transcatheter Heart Valve Replacement Machines 2018 - MedCore]]></title>
      <link>https://www.leadingmarketresearch.com/us-market-report-for-transcatheter-heart-valve-replacement-machines-2018</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">The primary method for treating heart valve conditions is through open surgery to place a replacement valve. Biological tissue valves can be allografts (provided by deceased donors), xenografts (bovine or porcine valves) or autografts (using the patient’s own pulmonary valve, which in turn, needs to be replaced). Tissue valves have been gaining popularity over the alternative mechanical valves because tissue valves are much more biocompatible and do not require lifelong treatment with 
anti-coagulant medication. However, mechanical valves are more durable and are designed to last for 
20-30 years, whereas bioprosthetic valves last 10-15 years. Some patients with heart valve problems are poor candidates for valve replacement surgery because they may be too ill to undergo such an invasive procedure. Therefore, there is a great deal of interest in the development of transcatheter heart valve replacement (THVR) devices. 
...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-200283"><span class="price">$2,995.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 17 Jan 2018 11:28:21 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[US Market Report for Remote Hemodynamic Monitoring Systems 2018 - MedCore]]></title>
      <link>https://www.leadingmarketresearch.com/us-market-report-for-remote-hemodynamic-monitoring-systems-2018-medcore</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">Remote hemodynamic monitoring devices are implanted into the patient to monitor the blood pressure in the pulmonary artery. The device takes measurements from inside the body and transmits the data to a secure website for clinicians to review. The clinicians are then able to preemptively able to detect heart failure and treat them before symptoms arise. ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-200292"><span class="price">$2,995.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 17 Jan 2018 11:28:21 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[US Market for Cardiac Surgery and Heart Valve Devices 2018 - MedView]]></title>
      <link>https://www.leadingmarketresearch.com/us-market-for-cardiac-surgery-and-heart-valve-devices-2018-medview</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">The U.S. market for cardiac surgery and heart valve devices includes tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter mitral valve repair (TMVR) devices, transcatheter heart valve replacement (THVR) devices, on-pump coronary artery bypass (ONCAB) devices, off-pump coronary artery bypass (OPCAB) devices, endoscopic vessel harvesting (EVH) devices, anastomosis assist devices (AADs), transmyocardial revascularization (TMR) devices, ventricular assist devices (VADs), intra-aortic balloon pumps, temporary artificial heart replacement devices, extracorporeal membrane oxygenation (ECMO), remote hemodynamic monitoring, patent foramen ovale (PFO), atrial septal defect (ASD) devices, ventricular septal defect (VSD) devices and left atrial appendage (LAA) devices. Several new and innovative devices within this market are expected to emerge over the forecast period, particularly in the heart valve and cardiac assist segments, and as a result, growth in the overall market is expected to accelerate....





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-200276"><span class="price">$3,995.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 17 Jan 2018 11:28:21 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[US Procedure Numbers for Cardiac Surgery and Heart Valve Devices 2018 - MedPro]]></title>
      <link>https://www.leadingmarketresearch.com/us-procedure-numbers-for-cardiac-surgery-and-heart-valve-devices-2018-med</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">Cardiac surgery and heart valve procedures accounts for a large array of procedures. Generally, cardiac surgery is done through open heart surgery where a surgeon opens the chest and heart. For heart valves, the surgeon could replace or repair the damaged heart valve. Another common cardiac surgery procedure would be coronary artery bypass grafting where a harvested vein is grafted onto the heart to bypass blocked arteries. This procedure can be done on-pump, where a cardioplegic solution is sued to stop the heart and the patient is put on a heart-lung machine, or off-pump, also known as beating heart surgery. ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-200277"><span class="price">$3,995.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 17 Jan 2018 11:28:21 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[US Product Portfolio for Cardiac Surgery and Heart Valve Devices 2018 - MedFolio]]></title>
      <link>https://www.leadingmarketresearch.com/us-product-portfolio-for-cardiac-surgery-and-heart-valve-devices-2018-med</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">Accurate product and industry research is a time consuming and costly affair, but a necessary part of any successful market player. Our MedFolio™ line of products can ease research burdens by compiling the latest product information across an entire market segment. We have aggregated hundreds of products by category and company, as well as comprehensive lists of press releases, regulatory announcements and future product developments. MedFolio is ideal for companies with small or limited research teams as well as those who need to supplement their research departments with new data. A MedFolio includes the following products (*Not all products are available in every MedFolio, for more information, consult the MedFolio product page of a specific report):
Executive Summary
Product Introductions
Product Portfolio (Current Products on Market)
Product Pipelines (Future Products)
Clinical Trials...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-200278"><span class="price">$1,995.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 17 Jan 2018 11:28:21 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[US Market Report for Ventricular Assist Devices 2018 - MedCore]]></title>
      <link>https://www.leadingmarketresearch.com/us-market-report-for-ventricular-assist-devices-2018-medcore</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">Ventricular assist devices (VADs) are used for aiding a failing heart by supplementing the pumping function of the heart. VADs are often used in patients with advanced heart failure (HF). HF is a chronic disease that occurs when degeneration of the heart muscle reduces the pump power of the heart, which causes the heart to become too weak to pump blood at a level sufficient to meet the body’s demands. The condition may be caused by arterial and valve diseases or cardiomyopathy, which is disease of the heart muscle itself. Other conditions such as high blood pressure or diabetes may also lead to HF. ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-200289"><span class="price">$3,495.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 17 Jan 2018 11:28:21 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[US Market Report for Temporary Artificial Heart Replacement Devices 2018 - MedCore]]></title>
      <link>https://www.leadingmarketresearch.com/us-market-report-for-temporary-artificial-heart-replacement-devices-2018</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">Artificial heart devices can be temporary or permanent mechanical devices that are designed to replace the function of a biological heart. The term “artificial heart” should not be used for describing ventricular assist devices (VADs). VADs are pumps that assist the heart but are not designed to replace it. Instead, they are used in collaboration with a patient’s heart. An artificial heart is also distinct from a cardiopulmonary bypass machine (CPB), which is an external device used for providing the functions of both the heart and lungs. CPBs are only used for a few hours at a time, most commonly during heart surgery. Artificial hearts were originally intended to be a permanent replacement for the biological human heart....





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-200291"><span class="price">$2,995.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 17 Jan 2018 11:28:21 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[US Market Report for Atrial and Ventricular Septal Defect Devices 2018 - MedCore]]></title>
      <link>https://www.leadingmarketresearch.com/us-market-report-for-atrial-and-ventricular-septal-defect-devices-2018-me</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">Atrial septal defect (ASD) and ventricular septal defect (VSD) are both conditions that involve incorrect blood flow within the heart. ASD is an opening in the muscular tissue that separates the sides of the heart’s two upper chambers. Due to blood reflux, the heart is made to work more strenuously and below its optimal level. The condition is more common in females than males and tends to get worse with time. If left untreated, ASD can cause hypertension, heart arrhythmia and even a stroke. As with patent foramen ovale (PFO), ASD can be treated with open-heart surgery, but the operation is highly invasive. ASDs are found in approximately 1 in 1,500 live births and can lead to death if not treated in some cases. ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-200294"><span class="price">$2,995.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 17 Jan 2018 11:28:21 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[BRIC Interventional Cardiology Procedures Outlook to 2021]]></title>
      <link>https://www.leadingmarketresearch.com/bric-interventional-cardiology-procedures-outlook-to-2021</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData’s new report, &quot;BRIC Interventional Cardiology Procedures Outlook to 2021&quot;, provides key procedures data on the BRIC Interventional Cardiology Procedures. The report provides procedure volumes within market segments - Angiography Procedures, Balloon Angioplasty Procedures, Coronary Stenting Procedures, PTCA Drug Eluting Balloon (DEB) Angioplasty Procedures and Percutaneous Coronary Intervention (PCI) Procedures.<br><br>The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.<br><br>The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based f...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-179636"><span class="price">$1,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 23 Jun 2016 09:26:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[BRIC Prosthetic Heart Valve Procedures Outlook to 2021]]></title>
      <link>https://www.leadingmarketresearch.com/bric-prosthetic-heart-valve-procedures-outlook-to-2021</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData’s new report, &quot;BRIC Prosthetic Heart Valve Procedures Outlook to 2021&quot;, provides key procedures data on the BRIC Prosthetic Heart Valve Procedures. The report provides procedure volumes within market segments - Conventional Aortic Valve Replacement Procedures, Conventional Mitral Valve Procedures and Transcatheter Heart Valve (THV) Procedures.<br><br>The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.<br><br>The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.<br><br>Extensive inter...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-179637"><span class="price">$1,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 23 Jun 2016 09:26:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[European Market Report for Electromyogram Monitoring 2016 - MedCore]]></title>
      <link>https://www.leadingmarketresearch.com/european-market-report-for-electromyogram-monitoring-2016-medcore</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">Electromyograph (EMG) devices measure the electrical activity in muscles and the functionality of the nervous system to find the cause of muscle malfunctions. Disorders causing nerve impairment can affect muscle function, due to improper firing of electrical pulses. Some examples of nervous system complications include: amyotrophic lateral sclerosis (ALS), carpal tunnel syndrome and myasthenia gravis (MG). EMG monitoring and diagnostic capabilities are limited to nerve and muscle function and are not able to diagnose brain or spinal cord diseases....





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-178802"><span class="price">$6,495.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 21 Jun 2016 12:24:19 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[China Interventional Cardiology Market Outlook to 2021]]></title>
      <link>https://www.leadingmarketresearch.com/china-interventional-cardiology-market-outlook-to-2021</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData’s new report, &quot;China Interventional Cardiology Market Outlook to 2021&quot;, provides key market data on the China Interventional Cardiology market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Drug Eluting Balloon (DEB) Catheters.<br><br>The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.<br><br>The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-175630"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 10 Jun 2016 09:19:34 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Mexico Prosthetic Heart Valves Market Outlook to 2021]]></title>
      <link>https://www.leadingmarketresearch.com/mexico-prosthetic-heart-valves-market-outlook-to-2021</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData’s new report, &quot;Mexico Prosthetic Heart Valves Market Outlook to 2021&quot;, provides key market data on the Mexico Prosthetic Heart Valves market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves.<br><br>The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.<br><br>The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.<br><br>The epidemiology-based forecasting model makes use of epidemiology da...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-175651"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 10 Jun 2016 09:19:34 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[North America Interventional Cardiology Market Outlook to 2021]]></title>
      <link>https://www.leadingmarketresearch.com/north-america-interventional-cardiology-market-outlook-to-2021</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData’s new report, &quot;North America Interventional Cardiology Market Outlook to 2021&quot;, provides key market data on the North America Interventional Cardiology market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Drug Eluting Balloon (DEB) Catheters.<br><br>The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and countries in the region, information related to pipeline products, news and deals is available in the report.<br><br>The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide informatio...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-174803"><span class="price">$3,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 06 Jun 2016 19:30:20 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Asia-Pacific Interventional Cardiology Market Outlook to 2021]]></title>
      <link>https://www.leadingmarketresearch.com/asia-pacific-interventional-cardiology-market-outlook-to-2021</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData’s new report, &quot;Asia-Pacific Interventional Cardiology Market Outlook to 2021&quot;, provides key market data on the Asia-Pacific Interventional Cardiology market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Drug Eluting Balloon (DEB) Catheters.<br><br>The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and countries in the region, information related to pipeline products, news and deals is available in the report.<br><br>The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-174812"><span class="price">$3,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 06 Jun 2016 19:30:20 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[BRIC Interventional Cardiology Market Outlook to 2021]]></title>
      <link>https://www.leadingmarketresearch.com/bric-interventional-cardiology-market-outlook-to-2021</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData’s new report, &quot;BRIC Interventional Cardiology Market Outlook to 2021&quot;, provides key market data on the BRIC Interventional Cardiology market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Drug Eluting Balloon (DEB) Catheters.<br><br>The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and countries in the region, information related to pipeline products, news and deals is available in the report.<br><br>The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-174817"><span class="price">$3,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 06 Jun 2016 19:30:20 +0000</pubDate>
    </item>
  </channel>
</rss>
